WeVote
Log In

Bill

Bill

A 1057

Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations

2025 Regular Session Introduced by Scott Bendett and 9 co-sponsors

Allows NY public and nonpublic K-12 schools to possess and administer FDA-approved opioid reversal agents in emergencies by trained staff, speeding treatment and saving lives.

REFERRED TO EDUCATION
0
WeVote Research Nonpartisan
Bill Summary · A 1057

Summary of Assembly Bill A 1057

Overview

Assembly Bill A 1057 would authorize New York schools to possess and administer FDA-approved opioid reversal agents in emergency situations. The bill is currently in the Education Committee, with its status listed as “REFERRED TO EDUCATION” after introduction on January 8, 2025.

Purpose and Intent

  • Improve emergency response to potential opioid overdoses on school grounds or at school-sponsored events.
  • Enable trained school personnel to administer an opioid reversal agent when an overdose is suspected or imminent, thereby reducing time to treatment and increasing the chances of a positive outcome.

Key Provisions (as stated)

  • Authorizes schools (districts and potentially other school entities) to possess FDA-approved opioid reversal agents.
  • Allows administration of these reversal agents by trained school personnel in emergency situations.
  • The bill designates opioid reversal agents (FDA-approved) as appropriate for emergency use within the school setting.

Note: The available summary does not specify districts, training requirements, storage, consent, or liability protections. These elements are commonly addressed in related legislation, but would require reading the full text or amended language for precise details.

Who is Affected

  • Primary: Public and possibly nonpublic K-12 schools, school districts, and school administration personnel.
  • Secondary: Students, staff, and visitors who could experience an opioid overdose at school or during school-sponsored activities.

Procedural and Timeline Aspects

  • Introduced: January 8, 2025.
  • Current status: Referred to the Education Committee (listed twice in the record, both on January 8, 2025, indicating a single committee referral in the official actions).

Sponsorship

  • Primary Sponsor: Maritza Davila.
  • Cosponsors: Scott H. Bendett, John Lemondes, Andrew Hevesi, Catalina Cruz, Al Taylor, Keith Brown, Albert A. Stirpe, Matthew Slater, Philip Ramos (various as cosponsors).

Related Legislation

  • A 10634 (prior-session).
  • A 2114 (prior-session). These related bills may address similar topics or offer alternative approaches in earlier sessions.

Potential Impact and Considerations

  • Positive impact: Faster access to life-saving treatment in overdose emergencies within schools, potentially saving lives.
  • Implementation considerations: Training requirements, stock and storage standards, parental consent policies (if applicable), supervision, and liability or immunity for responders. The bill’s current summary does not specify these details, which are typically addressed in the full text or subsequent amendments.

Next Steps

If advanced, the bill would move through committee hearings, potential amendments, and a floor vote in the Assembly. Subsequent steps would include passage by the Senate (if applicable) and potential negotiations before enactment.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.